- Vienna 2018
- Athens 2019
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
First Author: J.Izquierdo PERU
Co Author(s): R. Fernandez D. Dañin
Back to previous
To evaluate the safety and efficacy of the endocyclophotocoagulation (ecp) as a surgical treatment for glaucoma
Oftalmosalud, Lima Peru
Eighteen eyes from sixteen patients with primary open angle glaucoma and cataract from Oftalmo Salud, that underwent an uncomplicated surgery from september 2011 to january 2013, with at least 6 months of follow-up were prospectively enrolled. the inclusion criteria ages between 18 and 85 years old, intaocular pressure (iop)more than 22mmhg and less of 55mmhg, previous surgery of trabeculectomy, drainage device, cataract or both.qualified succes was defined as 5 mmhg iop and less of 21 mmhg with or without topical antiglaucomatous drug.
61% of the patients underwent ecp alone and 38.9% phaco and ecp.the preoperative iop was 22.5 +- 9.09 and the last appointment 13.72 +-3.9 mmhg, so we found significative difference between both (p=0.001), as the number of preoperative medications 1.72, post surgery 1.06 (p=0.006). we didnt find any difference between the best correctect visual acuity in patients underwent ecp alone or phaco and ecp.
The endocyclophotocoagulation is safe and effective in the treatment of refractory glaucomas, preserving the visual acuity, when underwent in combination or alone.